AAP
TMDX icon

Arax Advisory Partners’s Transmedics TMDX Stock Holding History

Arax Advisory Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.8K Buy
449
+359
+399% +$30.4K ﹤0.01% 3680
2026
Q1 		$6.49K Buy
90
+21
+30% +$2.74K ﹤0.01% 2666
2025
Q4 		$8.39K Sell
69
-68
-50% -$8.53K ﹤0.01% 2563
2025
Q3 		$15.4K Buy
137
+43
+46% +$5.03K ﹤0.01% 2397
2025
Q2 		$12.6K Buy
94
+1
+1% +$110 ﹤0.01% 1864
2025
Q1 		$6.26K Buy
+93
New +$6.4K ﹤0.01% 1706

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Arax Advisory Partners's TMDX Position: Q2 2026 in Review

Arax Advisory Partners increased its Transmedics (TMDX) stake by 399% in Q2 2026, buying an estimated $30.4K and bringing the position to 449 shares worth $29.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3680.

Arax Advisory Partners first reported a position in TMDX in Q1 2025 and has held it in 6 quarters since. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Arax Advisory Partners held 449 shares of Transmedics worth $29.8K as of Q2 2026.
  • Arax Advisory Partners bought 359 Transmedics shares in Q2 2026, an estimated $30.4K.
  • Transmedics made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3680 holding.
  • Arax Advisory Partners first reported a position in Transmedics in Q1 2025 and has held it in 6 quarters since.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.